| Description |
i, 81 p. : digital, PDF file |
| System Details |
System requirements: Adobe Acrobat Reader. |
|
Mode of access via the GAO web site. |
| Note |
Title from title screen (viewed on Nov. 23, 2008). |
|
"November 2008." |
| Summary |
In 2003, the Centers for Disease Control and Prevention (CDC), an agency within the Department of Health and Human Services (HHS), developed an electronic syndromic surveillance system called BioSense that uses health-related data to identify patterns of disease symptoms prior to specific diagnoses. In late 2007, CDC began to redesign the program to improve collaboration with stakeholders and address identified management weaknesses. Pursuant to House Report 110-231, GAO evaluated the BioSense program, focusing on the cost and timeline estimates and performance measures and benchmarks for implementing the program, among other objectives. |
| Bibliography |
Includes bibliographical references. |
| Note |
"GAO-09-100." |
| Subject |
Centers for Disease Control and Prevention (U.S.) -- Appropriations and expenditures.
|
|
Public health surveillance -- United States.
|
|
Interagency coordination -- United States.
|
|
Information networks -- United States.
|
|
Bioterrorism -- United States -- Prevention.
|
|
Information storage and retrieval systems -- Public health -- United States.
|
|
Communicable diseases -- United States -- Prevention.
|
| Added Title |
More detailed plans needed for the Centers for Disease Control and Prevention's redesigned BioSense program |
| Running Title |
CDC's redesigned BioSense program |
| Gpo Item No. |
0546-D (online) |
| Sudoc No. |
GA 1.13:GAO-09-100 |
|
